Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02087267
Other study ID # SITONA_01/2014
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 2014
Est. completion date December 1, 2022

Study information

Verified date December 2022
Source Sitona AG
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of the PMCF is to collect outcome information on patients suffering from symptomatic degenerative disc disease or degenerative spondylolisthesis requiring 1- or 2-level lumbar or lumbar-sacral spinal fusion with posterior instrumentation and therefore receiving the icotec CF/PEEK Pedicle System in combination with the icotec CF/PEEK TLIF Cage ETurn™.


Description:

Background: At present, metal pedicle screw systems made from titanium or stainless steel are commonly used for posterior stabilization. One disadvantage of theses metal devices is that they cause shadows and artifacts on CTs and MRIs which may hamper the postoperative exploration of the onset of spinal diseases and in particular the evaluation of the neuroforamina, the spinal canal and bone-implant interfaces. Therefore new concepts of pedicle screw devices use non-radiopaque materials such as carbon fiber-reinforced polyetheretherketone (CF/PEEK) without compromising mechanical properties compared to standard titanium implants and possibly reducing the risk for adjacent segment diseases. Description of the study devices: The icotec Pedicle System is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of acute and chronic instabilities or deformities of the thoracic, lumbar and sacral spine. The carbon fiber-reinforced polyetheretherketone (CF/PEEK) that is used to produce the icotec pedicle system rod and screw shaft is a thermoplastic composite biomaterial exhibiting properties suitable for load-bearing orthopedic implants. The CF/PEEK material does not cause artifacts or shadows on adjacent tissues with all imaging modalities such as x-ray, CT, and MRI. Radiopaque markers or fibres made from titanium or tantalum are embedded. The pedicle system rod and screws allow this advantage to be realized without compromising mechanical properties compared to standard titanium implants. Description of the study device - icotec CF/PEEK TLIF Cage ETurn: The icotec ETurn™ TLIF cage consists of a windowed body with a central slot, a distraction/ insertion wedge and surface treads on its cranial and caudal surfaces that serve to guide and anchor the implant (see figure 4). The concentrically arranged treads enable the implant to turn on its own from its position of insertion into the disc space to its transverse end position. The tread surfaces help to create a significantly larger pressure-bearing contact surface between the implant and the bone than the conventional pointed anchoring elements. Risk Analysis and risk Management: Most of the risks of implant related, surgical and postoperative complications associated with the implantation of the icotec CF/PEEK Pedicle System in combination with the icotec ETurn™ TLIF cage, are comparable to the risks associated with other TLIF surgeries with cages and pedicle screw systems intended for lumbar spine stabilization. risks and possible adverse outcomes have been identified for the icotec CF/PEEK Pedicle System as well as for the CF/PEEK TLIF Cage ETurn. Legal Aspects: For this post-market investigation only CE-marked medical devices will be used within their intended purpose and no additional invasive or other stressful examinations are to be carried out. All subjects will voluntarily sign the Informed Consent document. Ethics approval for the study will be obtained prior to starting the study Data Monitoring: Independent on-site Monitoring will be performed at all investigational sites.


Recruitment information / eligibility

Status Completed
Enrollment 94
Est. completion date December 1, 2022
Est. primary completion date December 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Symptomatic degenerative disc disease or degenerative spondylolisthesis grade 1 or 2 with chronic low back pain, pain in the leg or buttock, muscle weakness, sensation abnormalities and/or neurogenic claudication - Unsuccessful adequate conservative treatment - 1- or 2- contiguous level lumbar spinal fusion between L2 and S1 with posterior instrumentation in combination with Transforaminal Lumbar Interbody Fusion (TLIF) - Age between 18 - 80 years at the time of surgery - Skeletally mature patient - Patient understands the conditions of the study and is willing and able to comply with the postoperative scheduled clinical and imaging evaluations and the prescribed rehabilitation - Patient signed Informed Consent Exclusion Criteria: - No adequate non-operative care prior to being treated with a lumbar fusion device - 3-level fusion or more - Fusion not between L2 and S1 - Previous lumbar spinal surgery, other than discectomy at the level(s) to be operated on - Spondylolisthesis acc. to Meyerding grade 3 or higher - Transforaminal access to the disc space is obstructed - Use of bone grafts other than autologous grafts, demineralized bone matrix without additional growth factors and synthetic bone substitute without additional growth factors. Growth factor enhanced grafts, cement or any other graft material are excluded. - Adiposity, severe obesity (BMI > 35 kg/m2) - Any contraindication for MRI scan including heart pacemaker, metallic foreign body (metal sliver) in the eye or brain, aneurysm clip in the brain, severe claustrophobia etc. - Discitis, spondylodiscitis - Acute or chronic infection, previous surgical site infection or severe defect of the osseous structures - Open wounds - Patient who takes immunosuppressive or long-term steroid use - Fever - Allergy or intolerance to any device material (e.g. Carbon/PEEK, titanium or tantalum) - Foreign body sensitivity - Insufficient form fit between the implant and the bone owing to deformation or destruction of the pedicles or of the vertebral body end plates - Risk that the intervertebral device can subside into the vertebral bodies - Bone tumors in the region of the implant anchoring - Severe osteoporosis or similar bone density loss, incl. any metabolic bone disease - Cases, in which the progression of degenerative disease is so advanced at the time of implantation that it may substantially decrease the expected useful life of the appliance - Systemic or metabolic illnesses (i.e. insulin-dependent diabetes) - Patient who is suffering from rheumatological or other inflammatory joint disease - Paralysis of lower extremity - Generally poor condition of the patient - Psychosocial issues; lack of co-operation by the patient - Drug abuse or alcoholism - Any medical or surgical condition that could preclude the potential success of the implantation - Any condition not described in the indications for use - Unwillingness or inability of the patient to follow the instructions for postoperative treatment or with the follow-up evaluation schedule - Female patient who is pregnant or plans to become pregnant during the course of the study - Prisoner - Patient who has not signed the Informed Consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
1- or 2-level spinal fusion
1- or 2-level lumbar or lumbar-sacral spinal fusion with the icotec CF/PEEK Pedicle System in combination with the icotec CF/PEEK TLIF Cage ETurn™

Locations

Country Name City State
Germany Orthopädische Universitätsklinik Friedrichsheim gGmbH Frankfurt am Main
Germany Städtisches Klinikum Görlitz gGmbH, Klinik für Neurochirurgie Görlitz
Germany DIAKOVERE Annastift - Orthopädische Klinik der MHH Hannover
Germany Universitätsklinikum SH Klinik für Neurochirurgie Kiel Schleswig-Holstein
Germany Katholisches Klinikum, Brüderhaus Koblenz Koblenz
Switzerland Kantonsspital St. Gallen Klinik für Orthopädische Chirurgie und Traumatologie des Bewegungsapparates St. Gallen

Sponsors (1)

Lead Sponsor Collaborator
Sitona AG

Countries where clinical trial is conducted

Germany,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall fusion rate Outcome Measure by CT/MRI and clinical follow-up 2 years postoperatively
Secondary Rate of pedicle system implant failures Outcome Measure by CT/MRI and clinical follow-up 2 years postoperatively
Secondary Rate of implant related, surgery related, postoperative and general complications Outcome Measure by CT/MRI and clinical follow-up 2 years postoperatively
Secondary Rate of subsequent surgical interventions Outcome Measure by CT/MRI and clinical follow-up 2 years postoperatively
Secondary Change of the mean total Oswestry Low Back Pain Disability Questionnaire (ODI) clinical follow-up Change from the preoperative baseline to the 2 year postoperative assessment
Secondary Change of the mean Visual Analogue Scale (VAS) on low back pain clinical follow-up Change from the preoperative baseline to the 2 year postoperative assessment
Secondary Change of the mean Visual Analogue Scale (VAS) on pain in the leg and buttock (experienced in the pain-dominant leg) clinical follow-up Change from the preoperative baseline to the 2 year postoperative assessment
Secondary Visual Analogue Scale (VAS) on patient's satisfaction with the surgery clinical follow-up 2 years postoperatively
Secondary Change of the mean disc height at index level Outcome Measure by CT/MRI and clinical follow-up Change from the preoperative baseline to the 2 year postoperative assessment
Secondary Rate of symptomatic adjacent segment disease Outcome Measure by CT/MRI and clinical follow-up 2 years postoperatively
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05114135 - TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study) N/A
Recruiting NCT04378543 - Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion Phase 1/Phase 2
Withdrawn NCT03223701 - Efficacy of Using Solum IV and BMC With GFC in TLIF Phase 4
Not yet recruiting NCT06000319 - Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Not yet recruiting NCT05538416 - Short-term Clinical Outcome of Cortical Bone Trajectory Compared With the Traditional "Open" and Minimal Invasive Posterior Lumbar Interbody Fusion
Completed NCT00996073 - Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion Phase 2
Withdrawn NCT02530775 - "Is Instrumentation Necessary for "Static" Degenerative Spondylolisthesis" N/A
Terminated NCT03570801 - SLIP II Registry: Spinal Laminectomy Versus Instrumented Pedicle Screw Fusion N/A
Enrolling by invitation NCT04418830 - Lumbar Interbody Implant Study
Completed NCT03303300 - The Five-repetition Sit-to-stand Test for Lower Back Pain or Radiculopathy N/A
Withdrawn NCT00810212 - Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion Phase 1/Phase 2
Terminated NCT04483297 - First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) Phase 1
Completed NCT03898232 - Fibergraft Interbody Fusion Retrospective
Completed NCT00726310 - Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability
Recruiting NCT06154005 - OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion Phase 1/Phase 2
Completed NCT04418817 - Modulus in XLIF Study
Terminated NCT01528072 - Dynesys Spinal System Post Market 522 Study N/A
Active, not recruiting NCT03733626 - Clinical Outcomes Associated With the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease N/A
Active, not recruiting NCT05993195 - Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion
Recruiting NCT06394089 - Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: Study Protocol